This compound is a small-molecule inhibitor targeting FMS-related receptor tyrosine kinase-3. It is under investigation for potential antineoplastic activity and is primarily used as a research compound in kinase studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 885692-52-4
Sitravatinib
pharmaceutical raw material
Liranaftate
pharmaceutical raw material
Fosinopril sodium
pharmaceutical raw material
Mesalazine
pharmaceutical raw material
Salicylhydroxamic acid
pharmaceutical raw material
5-cyano-N-[2-(cyclohexen-1-yl)-4-[1-[2-(dimethylamino)acetyl]piperidin-4-yl]phenyl]-1H-imidazole-2-carboxamide
GUBJNPWVIUFSTR-UHFFFAOYSA-N
CN(C)CC(=O)N1CCC(CC1)C2=CC(=C(C=C2)NC(=O)C3=NC=C(N3)C#N)C4=CCCCC4